Skip to main content
Year archive

NAVCO Pharmaceuticals — 2019 filings

All 15 regulatory filings released by NAVCO Pharmaceuticals (NAV) in 2019, sourced directly from the official regulator.

15 Filings
2019 Period
2019 filings (15)
Filing Released Lang
Interim financial statements/report – English.pdf
Regulatory Filings
2019-11-14 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2019-11-14 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings
2019-10-18 English
Annual MD&A - English.pdf
Regulatory Filings
2019-10-18 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings
2019-10-18 English
News release - English.pdf
Regulatory Filings
2019-10-01 English
Notice of meeting - English.pdf
Regulatory Filings
2019-09-24 English
Notice of the meeting and record date - English.pdf
Regulatory Filings
2019-08-24 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2019-05-30 English
Interim MD&A - English.pdf
Regulatory Filings
2019-05-30 English
Interim financial statements/report – English.pdf
Regulatory Filings
2019-05-30 English
Interim financial statements/report – English.pdf
Regulatory Filings
2019-02-28 English
Interim MD&A - English.pdf
Regulatory Filings
2019-02-28 English
Material change report - English.pdf
Regulatory Filings
2019-02-25 English
News release - English.pdf
Regulatory Filings
2019-02-25 English